Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01020903 · ClinicalTrials.gov registry record · NA
Aprepitant for Post-operative Nausea
A NA study, sponsored by Northwell Health.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT01020903 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 200 participants.
The verdict
NCT01020903, a NA study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Anesthesia, especially for laparoscopic surgery, can cause post-operative nausea and vomiting. Most patients are given two drugs, decadron and ondansetron, to try to minimize this. This study is to determine if a new drug, aprepitant, would add any benefit in terms of post-op nausea prevention. All laparoscopic cholecystectomy study patients will receive decadron and ondansetron. Half the patients will receive aprepitant in addition. The other half will receive placebo. The study will be randomized and double-blind.
Interventions
- DRUG Placebo
- PROCEDURE Aprepitant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01020903
The ClinicalTrials.gov registry entry for NCT01020903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01020903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01020903 about?
NCT01020903 is a clinical study titled "Aprepitant for Post-operative Nausea". Anesthesia, especially for laparoscopic surgery, can cause post-operative nausea and vomiting. Most patients are given two drugs, decadron and ondansetron, to try to minimize this. This study is to determine if a new drug, aprepitant, would add any benefit in terms of post-op nausea prevention. All ...
What is the current status of trial NCT01020903?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2009-11. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01020903?
The interventions under investigation include: Placebo (DRUG), Aprepitant (PROCEDURE).
Who is sponsoring clinical trial NCT01020903?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.